{"name":"Thetis Pharmaceuticals LLC","slug":"thetis-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Metformin HCl and Vascepa","genericName":"Metformin HCl and Vascepa","slug":"metformin-hcl-and-vascepa","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Metformin HCl and Vascepa","genericName":"Metformin HCl and Vascepa","slug":"metformin-hcl-and-vascepa","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOQkMwT1VXTkEtOEgwQWVUMW42WkxjT291S0dXdDVCQ21PcG5sYm9STUhmODdSRi1YckJ0QzdzSWM3Q3NrUVFZMEhnM0RFNUpuOHFwT3NQV2RJMzA0S1dDcnpqOU4zR2JtMzRHa0RxRDlaQ0xfQVY3NldTUl9JeXBZbFdEYUJHRFRjcWZSMktQemplaHNGemt6dTk4ZDRaQkZRVzlSdDgxRmM0RmltY2JPQk80MEItSnV5VWtNUi1HM0x2czVNUDBwREw2emtqOVlQVjZvejA1Qkk3UTVPODljX2NCTmlpZDNqeFlyQnZkTlA3bG1RajZR?oc=5","date":"2026-02-12","type":"pipeline","source":"Business Wire","summary":"Thetis Pharmaceuticals Expands Scientific Advisory Board with Leading Experts in Inflammatory Bowel Disease - Business Wire","headline":"Thetis Pharmaceuticals Expands Scientific Advisory Board with Leading Experts in Inflammatory Bowel Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOa2VCZUcwSEVDcWxrVmZMaW1ZZmpNVUYtR3k4VEdSbEhUaTRzRW1WakZhaEpVYUVPdkJRSVNWdEFDd19ORzI3cG5GdFFYcF8zTlhlTGRwX3l1c0NjcXhucDdfTmxjX3JpYkJQVXMteUxvaGFmQWJMdDFmckRpX1VvMHkwSEt2RTFVXy1ack03RUhvOW1uRkpYc2Jua2QyMjl5T2hHbjB1elhjQVI3S1hqTnVxb0NIY1ZFaHFIaVhrWXVQeEdwY1Y0bmVpVldhRnpaNlc0Q1FGZWMzLWQ5?oc=5","date":"2025-05-05","type":"trial","source":"Business Wire","summary":"Thetis Pharmaceuticals Presents New Preclinical and Clinical Data forTP-317 at DDW 2025 - Business Wire","headline":"Thetis Pharmaceuticals Presents New Preclinical and Clinical Data forTP-317 at DDW 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQbGdvVFdOQkQyQ016WmtQQ2ZTRU81cWE1VnFFNnFMd2t5bU41Nzh6UURXcVk1YkRHWGkxYlFsMzU1U3VKYnBobGgxSUNBRXZ2VmZiaXhqUnRsclhZbTBIVURxSlF0UmZDM3I4R2E2M0pqcUdSRTdDdDlJdi16QjBCZWU2SzJlalVnXzd1M2kyVFVBaDZ0Rmp1ZlBDeEUtY0FSOHUzN1hiSjAtSWdXN1NWQnZDTE9nbXJGb1VSUkdEQmJFV1ZTcTRkb3lVMVFkcWJyM1ljQTBYSWh1M3BwaTBoMFFVYWJuRHNTYlNjNA?oc=5","date":"2025-04-15","type":"pipeline","source":"PR Newswire UK","summary":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire UK","headline":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPSk92bTJmTDV0bHVpX3c5UUdXaDZNSWRtUmV4RVQtdEZ6S2JSYUs4V2pZOGo0c25tckJDNUs0eUxNUmZJd2l2Z0dxTHFYT3hjTkc1LXFiX0NLc1ptWUtTM3I2UzcwVTdzMWhMOWt5ZTFWNklsMEJjZ2w1RHV5QnRlMGFWRVVmZV9CQ1ptb0tZTU52aDBPWkg0WEdpNzVna3ZCWDJaeUhqVjNGTmkyeTBpSlhtNFdNaUZJQTVJaDRQSk9BOG1FbEJsTXRB?oc=5","date":"2025-02-21","type":"pipeline","source":"BioWorld News","summary":"Thetis Pharmaceuticals' TP-317 shows promising effects in experimental colitis and ileitis - BioWorld News","headline":"Thetis Pharmaceuticals' TP-317 shows promising effects in experimental colitis and ileitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQZW5RNTVsemNhcm4xanlLYV9kSVhhT1VzcXNWOEVWUlpxR1F6YkV0dHo4d1hMNHlkLTNmYlVUUzl4U0h2dGcxejVPZlZqNTZaQk5iNFVzWlJpaE9pa0JLUklBbmZ2ODZvOVFpNWxQTjFSbnFLcmppRFdMUlpxc0FqUjhQTmduUjV5ZFlxNmtNT2stQ3JXV2ktWF9PbVdOcDBPZFRTbDRNN05UWVBNeVhURWtJeng4bERnSFVfcHRn?oc=5","date":"2025-01-09","type":"pipeline","source":"Hartford Business Journal","summary":"CT biotech firm secures $9M to advance oral treatment for inflammatory bowel disease - Hartford Business Journal","headline":"CT biotech firm secures $9M to advance oral treatment for inflammatory bowel disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPOHVCcmNFWnFfNWFrSlpkSHB5MDVUZ3hXdlowR1N3ZjE5aGhKbkV2MDduVzZzWnBhN2l1QVZRdWJWZ2NldUlQUHVublJzNm5VT2dSRF9SM29yTWJoM21ERldOUXU3dTlJeEF0cXQzd2xFNzE4dlZFWDRiUjRWaU1OVk5Ndk9UYllBanNTb0hnSjZQY2pJNFhRc19jZUNjQ2Ytc3VSTXFlOHQ0cmdGUmtSSEdjNkVtRkVneEpRbUNZdVB3cWlqUV8zSldFeFNRYWNuTFdvdUtB?oc=5","date":"2024-11-14","type":"pipeline","source":"citybiz","summary":"Thetis Pharmaceuticals Appoints Fabio Cataldi, M.D., to Board of Managers and Scientific Advisory Board - citybiz","headline":"Thetis Pharmaceuticals Appoints Fabio Cataldi, M.D., to Board of Managers and Scientific Advisory Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNNVdlU0RzR3NUQy03SnJndGYyUmpKQy1zN0x0dHQxU29aZ2VVTElmcERwcWdFZUdFZVJPYnUwZ2JtdEY5OGpWOFpSWjhyLWNXTk05LVhrUFVZRUxGc2UyQ1ZQRVYycUEzU2pKdTlEWmM5UWZnRnV1VmlER1BFSU9tRXBKTVJQS21Pam1pbVhSLVZWNjZNQzJ5ZWpmdDZ2bWNCTjVIYU90Z0hlVWFXbjF3bzFxemxNUnM0dV9yMWR3a1FfM2YwNkwwd0xaRmNoMXFlWGxiQlBPanExVDl3S292RA?oc=5","date":"2024-10-31","type":"trial","source":"BioSpace","summary":"Thetis Pharmaceuticals Announces Positive Initial Results From Phase 1a Study of TP-317 in Healthy Subjects - BioSpace","headline":"Thetis Pharmaceuticals Announces Positive Initial Results From Phase 1a Study of TP-317 in Healthy Subjects","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}